ESMA Calls For Transparency on Covid-19 Effects in Half-yearly Financial Reports
The European Securities and Markets Authority (ESMA), the EU Securities Markets regulator, yesterday published a Public Statement addressing the implications of the COVID-19 pandemic on the half-yearly financial reports of listed issuers.
The Public Statement provides recommendations on areas of focus identified by ESMA and highlights:
- the importance of providing relevant and reliable information, which may require issuers to make use of the time allowed by national law to publish half-yearly financial reports while not unduly delaying the timing of publication;
- the importance of updating the information included in the latest annual accounts to adequately inform stakeholders of the impacts of COVID-19, in particular in relation to significant uncertainties and risks, going concern, impairment of non-financial assets and presentation in the statement of profit or loss; and
- the need for entity-specific information on the past and expected future impact of COVID-19 on the strategic orientation and targets, operations, performance of issuers as well as any mitigating actions put in place to address the effects of the pandemic.
The Public Statement is also applicable to financial statements in other interim periods when IAS 34 Interim Financial Reporting is applied. It calls on the management, administrative and supervisory bodies, including audit committees, of issuers and, where applicable, their auditors, to take due consideration of the recommendations included within the statement. ESMA further emphasises the role of audit committees in promoting high-quality half-yearly financial reports at this difficult junction in time.
Latest News from
Parliament wants to grant EU consumers a “right to repair”27/11/2020 10:38:00
Parliament wants to boost sustainability by promoting reuse and repairs and by tackling practices that shorten the lifespan of products.
Steps to improve EU democracy ahead of 2024 elections27/11/2020 09:25:00
Parliament aims to enhance democracy and enable full participation in the European political space, based on lessons from the 2019 European elections.
MEPs set out blueprint for a new Industrial strategy27/11/2020 08:20:00
Parliament advocates a shift in the EU’s approach to industrial policy, to help businesses cope with the crisis and face the digital and environmental twin transitions.
Streamlining public procurement within the EU for more efficient public spending26/11/2020 16:43:00
The Council yesterday adopted a set of conclusions centred on how efficient public procurement rules and practices, combined with increased public spending, can accelerate the economic recovery from the COVID-19 crisis and lead to a sustainable and more resilient EU economy.
Orange the World: NO to violence against women26/11/2020 15:25:00
The European Parliament is again joining the UN's Orange the World campaign to combat violence against women.
MEPs call on EU leaders to end MFF deadlock without giving in on rule of law26/11/2020 14:33:00
EP group leaders and the Commission advise Hungary and Poland to take the EU to Court on rule of law, instead of penalising EU citizens by blocking the budget.
Affordable, accessible and safe medicines for all: the Commission presents a Pharmaceutical Strategy for Europe26/11/2020 13:25:00
The Commission yesterday adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU's pharmaceutical industry.
Successful third issuance of EU SURE bonds by the European Commission26/11/2020 12:38:00
The European Commission has issued a €8.5 billion social bond under the EU SURE instrument to help protect jobs and keep people in work.
Coronavirus: Commission approves contract with Moderna to ensure access to a potential vaccine26/11/2020 11:33:00
The European Commission yesterday approved a sixth contract under the EU Vaccines Strategy, this time with the pharmaceutical company Moderna.